Journal Article10.1056/NEJMOA1414792
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
Bruce C.V. Campbell,Leonid Churilov,Nawaf Yassi,Bernard Yan,M. Brooks,F. Miteff,Martin Krause,M. Priglinger,Timothy Ang,Rebecca Scroop,Ben McGuinness,Tissa Wijeratne,Winston Chong,Monica S Badve,H. Rice,L. de Villiers,Henry Ma,Abstr Act +17 more
TL;DR: In patients with ischemic stroke with a proximal cerebral arterial occlusion and salvageable tissue on CT perfusion imaging, early thrombectomy with the Solitaire FR stent retriever, as compared with alteplase alone, improved reperfusion, early neurologic recovery, and functional outcome.
read more
Abstract: Background Trials of endovascular therapy for ischemic stroke have produced variable results. We conducted this study to test whether more advanced imaging selection, recently developed devices, and earlier intervention improve outcomes. Methods We randomly assigned patients with ischemic stroke who were receiving 0.9 mg of alteplase per kilogram of body weight less than 4.5 hours after the onset of ischemic stroke either to undergo endovascular thrombectomy with the Solitaire FR (Flow Restoration) stent retriever or to continue receiving alteplase alone. All the patients had occlusion of the internal carotid or middle cerebral artery and evidence of salvageable brain tissue and ischemic core of less than 70 ml on computed tomographic (CT) perfusion imaging. The coprimary outcomes were reperfusion at 24 hours and early neurologic improvement (≥8-point reduction on the National Institutes of Health Stroke Scale or a score of 0 or 1 at day 3). Secondary outcomes included the functional score on the modified Rankin scale at 90 days. Results The trial was stopped early because of efficacy after 70 patients had undergone randomization (35 patients in each group). The percentage of ischemic territory that had undergone reperfusion at 24 hours was greater in the endovascular-therapy group than in the alteplase-only group (median, 100% vs. 37%; P<0.001). Endovascular therapy, initiated at a median of 210 minutes after the onset of stroke, increased early neurologic improvement at 3 days (80% vs. 37%, P = 0.002) and improved the functional outcome at 90 days, with more patients achieving functional independence (score of 0 to 2 on the modified Rankin scale, 71% vs. 40%; P = 0.01). There were no significant differences in rates of death or symptomatic intracerebral hemorrhage. Conclusions In patients with ischemic stroke with a proximal cerebral arterial occlusion and salvageable tissue on CT perfusion imaging, early thrombectomy with the Solitaire FR stent retriever, as compared with alteplase alone, improved reperfusion, early neurologic recovery, and functional outcome. (Funded by the Australian National Health and Medical Research Council and others; EXTEND-IA ClinicalTrials.gov number, NCT01492725, and Australian New Zealand Clinical Trials Registry number, ACTRN12611000969965.)
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Futile inter-hospital transfer for mechanical thrombectomy in a semi-rural context: analysis of a 6-year prospective registry.
Denis Sablot,Adrian Dumitrana,Franck Leibinger,Khaled Khlifa,Bénédicte Fadat,Geoffroy Farouil,Thibaut Allou,Francis Coll,Julie Mas,Philippe Smadja,Adelaïde Ferraro-Allou,Isabelle Mourand,Anais Dutray,Maxime Tardieu,Snejana Jurici,Jean-Marie Bonnec,Nadège Olivier,Sandra Cardini,Frederique Damon,Laurène Van Damme,Sabine Aptel,Nicolas Gaillard,Ana-Maria Marquez,Ludovic Nguyen Them,Majo Ibanez,Caroline Arquizan,Vincent Costalat,Alain Bonafe +27 more
TL;DR: None of the baseline factors could predict FT, but the initial symptom severity was associated with FT caused by clinical worsening/infarct growth, and longer than expected inter-hospital transfer time could not be identified.
33
Neurologic Emergencies in the Patients With Cancer: Diagnosis and Management
Andrew L. Lin,Edward K. Avila +1 more
TL;DR: The presentation, pathophysiology, and management of the most common causes of acute neurologic decompensation in the patient with cancer are reviewed.
33
Cost-Effectiveness Study of Initial Imaging Selection in Acute Ischemic Stroke Care
Gabriela Martinez,Gabriela Martinez,Jeffrey M. Katz,Ankur Pandya,Jason J. Wang,Artem Boltyenkov,Ajay Malhotra,Alvin I. Mushlin,Pina C. Sanelli +8 more
TL;DR: In this article, the authors analyzed the impact on outcomes of imaging utilization before treatment decisions at comprehensive stroke centers for patients presenting with suspected acute ischemic stroke (AIS) in the anterior circulation with last-known-well-to-arrival time 0 to 24 hours.
33
Endovascular Mechanical Thrombectomy with the Solitaire Device for the Treatment of Acute Basilar Artery Occlusion.
Xiaochuan Huo,Feng Gao,Xuan Sun,Ning Ma,Ligang Song,Dapeng Mo,Lian Liu,Bo Wang,Xuelei Zhang,Zhongrong Miao +9 more
TL;DR: Endovascular treatment with the Solitaire device yielded high recanalization rates in ABAO patients and favorable clinical outcomes in approximately one third of patients.
33
Added value of CT perfusion compared to CT angiography in predicting clinical outcomes of stroke patients treated with mechanical thrombectomy.
Ioannis Tsogkas,Michael Knauth,Katharina Schregel,Daniel Behme,Katrin Wasser,Ilko Maier,Jan Liman,Marios-Nikos Psychogios +7 more
TL;DR: CBV-ASPECTS is a significant predictor of clinical outcome in patients with acute ischemic stroke treated with mechanical thrombectomy, and single phase CTA-ASpECTS has low predictive value.
33
References
A Simple Sequentially Rejective Multiple Test Procedure
TL;DR: In this paper, a simple and widely accepted multiple test procedure of the sequentially rejective type is presented, i.e. hypotheses are rejected one at a time until no further rejections can be done.
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
Debbie Beumer,Debbie Beumer,Julie Staals,Jeannette Hofmeijer,Jelis Boiten,J. De Vries,Omid S. Eshghi,Koos Keizer,R. van den Berg,A. van der Lugt,Abstr Act +10 more
TL;DR: In patients with acute ischemic stroke caused by a proximal intracranial occlusion of the anterior circulation, intraarterial treatment administered within 6 hours after stroke onset was effective and safe.
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
Nils Wahlgren,Niaz Ahmed,Antoni Dávalos,Gary A. Ford,Martin Grond,Werner Hacke,Michael G. Hennerici,Markku Kaste,Sonja Kuelkens,Vincent Larrue,Kennedy R. Lees,Risto O. Roine,Lauri Soinne,Danilo Toni,Geert Vanhooren +14 more
TL;DR: These data confirm that intravenous alteplase is safe and effective in routine clinical use when used within 3 h of stroke onset, even by centres with little previous experience of thrombolytic therapy for acute stroke.
2K
•Journal Article
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study (vol 369, pg 275, 2007)
TL;DR: The Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) as discussed by the authors was required to assess the safety profile of intravenous alteplase in clinical practice by comparison with results in randomised controlled trials.
1.9K
Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke
Joseph P. Broderick,Yuko Y. Palesch,Andrew M. Demchuk,Sharon D. Yeatts,Pooja Khatri,Michael D. Hill,Edward C. Jauch,Tudor G Jovin,Bernard Yan,Frank L. Silver,Ruediger von Kummer,Carlos A. Molina,Bart M. Demaerschalk,Ronald F. Budzik,Wayne M. Clark,Osama O. Zaidat,Tim W. Malisch,Mayank Goyal,Wouter J. Schonewille,Mikael Mazighi,Stefan T. Engelter,Craig S. Anderson,Judith Spilker,Janice Carrozzella,Karla J Ryckborst,L. Scott Janis,Renee H Martin,Lydia D. Foster,Thomas A. Tomsick +28 more
TL;DR: The trial showed similar safety outcomes and no significant difference in functional independence with endovascular therapy after intravenous t-PA, as compared with intravenoust-PA alone.
Related Papers (5)
Jeffrey L. Saver,Mayank Goyal,Alain Bonafe,Hans-Christoph Diener,Elad I. Levy,Vitor Mendes Pereira,Gregory W. Albers,Christophe Cognard,David J. Cohen,Werner Hacke,Olav Jansen,Tudor G Jovin,Heinrich Mattle,Raul G Nogueira,Adnan H. Siddiqui,Dileep R. Yavagal,Blaise Baxter,Thomas Devlin,Demetrius K. Lopes,Vivek Y. Reddy,Richard du Mesnil de Rochemont,Oliver C. Singer,Reza Jahan +22 more
A. Chamorro,Erik Cobo,Alex Rovira,L. San Román,Joaquín Serena,Sònia Abilleira,Marc Ribo,Mónica Millán,Xabier Urra,Pedro Cardona,E. López-Cancio,Alejandro Tomasello,Carlos Castaño,Jordi Blasco,Lucia Aja,Laura Dorado,Helena Quesada,Marta Rubiera,María Hernández-Pérez,Mayank Goyal,R. von Kummer,Antonio Dávalos +21 more
Mayank Goyal,Bijoy K Menon,Wim H. van Zwam,Diederik W.J. Dippel,Peter Mitchell,Andrew M. Demchuk,Antoni Dávalos,Charles B. L. M. Majoie,Aad van der Lugt,Maria Angeles De Miquel,Geoffrey A. Donnan,Yvo B.W.E.M. Roos,Alain Bonafe,Reza Jahan,Hans-Christoph Diener,Lucie A. van den Berg,Elad I. Levy,Olvert A. Berkhemer,Vitor Mendes Pereira,Jeremy L. Rempel,Mónica Millán,Stephen M. Davis,Daniel Roy,John Thornton,Luis San Roman,Marc Ribo,Debbie Beumer,Bruce Stouch,Scott Brown,Bruce C.V. Campbell,Robert J. van Oostenbrugge,Jeffrey L. Saver,Michael D. Hill,Tudor G Jovin +33 more